DCGI asks states to keep vigil on sale of falsified versions of 2 critical drugs following WHO alerts

Additionally, the DCGI has requested state and regional regulatory offices to instruct their officers to maintain strict vigilance over the movement, sale, distribution, and stock of the mentioned drug products in the market.

Related Keywords

India ,Gentium Srl ,Adcetris Brentuximab Vedotin ,Defitelio Defibrotide ,Central Drugs Standard Control Organisation ,Takeda Pharmaceutical Company ,World Health Organization ,Drugs Controller General ,Takeda Pharmaceutical Company Limited ,Brentuximab Vedotin ,United Nations ,Cosmetics Act ,Adcetris Injection ,Drug Controller General ,Dgci ,Medicine ,Banned Drugs ,Who ,Defitelio ,Adcetris ,